AAV vector engineering for human aorta transduction: becoming a smooth operator

被引：0
|
作者：
Rapti, Kleopatra [1 ]
Grimm, Dirk [1 ,2 ,3 ,4 ]
机构：
[1] Heidelberg Univ, Sect Viral Vector Technol, Ctr Integrat Infect Dis CIID, Dept Infect Dis Virol,Med Fac,BioQuant, D-69120 Heidelberg, Germany
[2] German Ctr Infect Res DZ, D-69120 Heidelberg, Germany
[3] German Ctr Cardiovasc Res DZHK, Partner Site Heidelberg, D-69120 Heidelberg, Germany
[4] Heidelberg Univ, Fac Engn Sci, D-69120 Heidelberg, Germany
来源：
GENE THERAPY | 2025年
关键词：
MUSCLE-CELLS; EFFICIENT TRANSDUCTION; ADENOASSOCIATED VIRUS; GENE-TRANSFER; DELIVERY;
D O I：
10.1038/s41434-025-00526-9
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] AAV library screening identifies novel vector for efficient transduction of human aorta
    Lena C. Schröder
    Leonard Hüttermann
    Anca Kliesow Remes
    Jakob C. Voran
    Susanne Hille
    Wiebke Sommer
    Georg Lutter
    Gregor Warnecke
    Derk Frank
    Dennis Schade
    Oliver J. Müller
    Gene Therapy, 2025, 32 (2) : 154 - 162
  • [2] Stabilizing the rAAV Vector Genome Increases AAV Vector Transduction Efficiency
    Pokiniewski, Katie A.
    Moore, Andrea R.
    Dong, Biao
    Wang, Qizhao
    Xiao, Weidong
    MOLECULAR THERAPY, 2015, 23 : S269 - S269
  • [3] Protein transduction of AAV Rep 78 can support AAV vector packaging
    Hisayasu, S
    Adachi, K
    Kinoshita, H
    Hirai, Y
    Shimada, T
    MOLECULAR THERAPY, 2003, 7 (05) : S47 - S47
  • [4] Liver fibrosis impairs hepatocyte transduction by AAV vector
    Bruno, G.
    Ferriero, R.
    Piccolo, P.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A170 - A170
  • [5] AAV Transduction of MSCs is Enhanced by Genetic Engineering Medium
    Doolin, Mary
    Willstaedt, Therese
    Boychyn, Michael
    Rowley, Jon
    MOLECULAR THERAPY, 2023, 31 (04) : 233 - 234
  • [6] AAV Capsid Engineering to Improve Transduction in Retina and Brain
    Sullivan, Jennifer
    Stanek, Lisa
    Lukason, Michael
    Barry, Elizabeth
    Russell, Shayla
    Morris, James
    Mastis, Bryan
    Alves, Anna
    Bu, Jie
    Shihabuddin, Lamya S.
    Cheng, Seng
    Scaria, Abraham
    MOLECULAR THERAPY, 2016, 24 : S120 - S121
  • [7] Neutralizing anti-AAV antibody impact on vector transduction following intravitreal administration of AAV in non-human primates
    Shearman, M. S.
    Turunen, H. T.
    Newmark, J.
    Pennock, S.
    Timmers, A.
    HUMAN GENE THERAPY, 2019, 30 (11) : A115 - A116
  • [8] Effect of neutralizing anti-AAV antibodies on vector transduction following intravitreal administration of AAV in non-human primates
    Turunen, H. T.
    Timmers, A.
    Newmark, J.
    Pennock, S.
    Shearman, M. S.
    HUMAN GENE THERAPY, 2018, 29 (12) : A85 - A85
  • [9] Effect of Neutralizing Anti-AAV Antibodies on Vector Transduction Following Intravitreal Administration of AAV in Non-Human Primates
    Turunen, Heikki
    Timmers, Adrian M.
    Newmark, Judith
    Pennock, Steven
    Shearman, Mark S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [10] Engineering AAV Vector for the Delivery of Human BuChE to Protect Against Exposure to Organophosphates
    Medina-Jaszek, Angelica
    Ahokhai, Omua
    Taheri, Maryam
    Arif, Muhammad
    Tretiakova, Anna
    Wilson, James M.
    MOLECULAR THERAPY, 2016, 24 : S26 - S26
12345